GPX Medical AB (publ) deltar på Stockholm Corporate Finance Life Science-Seminarium imorgon, den 24 mars 2021, kl. 08.30 då vd Hanna Sjöström presenterar den senaste utvecklingen och framtiden för bolaget.

Stockholm Corporate Finance arrangerar kapitalmarknadsdagen för trettonde året i rad och erbjuder investerare, analytiker och media att träffa företag i Life Science & Healthcare branschen.

Presentationen streamas live och kan ses via länken: https://financialhearings.com/event/13774

Läs hela pressmeddelandet här: Pressmeddelande

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hanna.sjostrom@gpxmedical.se

Contact

GPX Medical AB (publ)
Tellusgatan 13
224 57 Lund
Sweden
info@gpxmedical.se

Organization number: 559069-9012